Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_assertion type Assertion NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_head.
- NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_assertion description "[The CFTR 5T polymorphism was identified in 31 of 334 (9.3%) patients of sporadic pancreatic cancer, in 5 of 43 (11.6%) patients with familial pancreatic cancer and in 10 of 112 (8.9%) controls with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_provenance.
- NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_assertion evidence source_evidence_literature NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_provenance.
- NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_assertion SIO_000772 14688470 NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_provenance.
- NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_assertion wasDerivedFrom befree-20140225 NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_provenance.
- NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_assertion wasGeneratedBy ECO_0000203 NP754602.RAQ5aojd0dOYfrAgICh2crH9BZ8eLCVPy0C3Mg7gG8bLs130_provenance.